Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1989;79:344-349

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gilbert, E. M.
Right arrow Articles by Bristow, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gilbert, E. M.
Right arrow Articles by Bristow, M. R.

Circulation, Vol 79, 344-349, Copyright © 1989 by American Heart Association


ARTICLES

Beta-adrenergic supersensitivity of the transplanted human heart is presynaptic in origin

EM Gilbert, CC Eiswirth, PC Mealey, P Larrabee, CM Herrick and MR Bristow
Utah Cardiac Transplant Program, Salt Lake City.

An increase in cardiac beta-adrenergic sensitivity or beta-receptor density or both has been described in several animal species after denervating the heart. The transplanted human heart is also denervated and, therefore, may exhibit supersensitivity to beta-adrenergic agonists and an increase in beta-adrenergic receptor density. In 16 patients examined 1-3 months after orthotopic cardiac transplantation, beta-adrenergic receptor density measured by [125I]iodocyanopindolol binding in endomyocardial biopsy specimens was not significantly different in transplant recipients compared with normal controls (transplant = 1,429 +/- 199, control = 1,728 +/- 263 fmol/g wet wt; p = NS). However, when normalized to Lowry protein, the [125I]iodocyanopindolol in beta-adrenergic receptor density in biopsy tissue from transplant recipients was significantly lower than in tissue from controls (transplant = 58.1 +/- 6.2, control = 93.5 +/- 13.4 fmol/g Lowry protein; p = 0.011). Atrial sinus node activity of the denervated donor heart and the innervated atrial cuff of the native recipient heart could be detected on the surface electrocardiogram in six patients. In these six patients, the heart rate response to graded infusions of epinephrine (taken up by the adrenergic nerve terminals) and isoproterenol (not taken up by the adrenergic nerve terminals) was measured. The epinephrine dose-response curve in transplanted donor atria was significantly to the left of the native recipient atrial dose- response curve (p less than 0.0001). The isoproterenol dose-response curves for native and transplanted atria were not different. We conclude that myocardial beta-adrenergic receptors are not increased in human orthotopic cardiac allografts and that there is no evidence for beta-receptor-mediated supersensitivity of postsynaptic origin.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
PsychosomaticsHome page
C. E. Come and P. A. Shapiro
Supraventricular Tachycardia Associated With Methylphenidate Treatment in a Heart Transplant Recipient
Psychosomatics, October 1, 2005; 46(5): 461 - 463.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
F. H. H. Leenen, E. Coletta, A. Fourney, and R. White
Aging and cardiac responses to epinephrine in humans: role of neuronal uptake
Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2498 - H2503.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
C. J Weisbrod, L. F Arnolda, D. J McKitrick, G. O'Driscoll, K. Potter, and D. J Green
Vasomotor responses to decreased venous return: effects of cardiac deafferentation in humans
J. Physiol., November 1, 2004; 560(3): 919 - 927.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
F. M. Bengel, P. Ueberfuhr, J. Karja, K. Schreiber, S. G. Nekolla, B. Reichart, and M. Schwaiger
Sympathetic reinnervation, exercise performance and effects of {beta}-adrenergic blockade in cardiac transplant recipients
Eur. Heart J., October 1, 2004; 25(19): 1726 - 1733.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. Wikstrand, A. k. Hjalmarson, F. Waagstein, B. j. Fagerberg, S. Goldstein, J. Kjekshus, H. Wedel, and MERIT-HF Study Group
Dose of metoprolol CR/XL and clinical outcomes in patients with heart failure: Analysis of the experience in metoprolol CR/XL randomized intervention trial in chronic heart failure (MERIT-HF)
J. Am. Coll. Cardiol., August 7, 2002; 40(3): 491 - 498.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
N. Delahaye, D. Le Guludec, S. Dinanian, J. Delforge, M. S. Slama, L. Sarda, F. Dolle, H. Mzabi, D. Samuel, D. Adams, et al.
Myocardial Muscarinic Receptor Upregulation and Normal Response to Isoproterenol in Denervated Hearts by Familial Amyloid Polyneuropathy
Circulation, December 11, 2001; 104(24): 2911 - 2916.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
F. M. Bengel, P. Ueberfuhr, N. Schiepel, S. G. Nekolla, B. Reichart, and M. Schwaiger
Effect of Sympathetic Reinnervation on Cardiac Performance after Heart Transplantation
N. Engl. J. Med., September 6, 2001; 345(10): 731 - 738.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. F. Wilson, T. H. Johnson, G. C. Haidet, S. H. Kubo, and M. Mianuelli
Sympathetic Reinnervation of the Sinus Node and Exercise Hemodynamics After Cardiac Transplantation
Circulation, June 13, 2000; 101(23): 2727 - 2733.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
B. Mettauer, Q. M. Zhao, E. Epailly, A. Charloux, E. Lampert, B. Heitz-Naegelen, F. Piquard, P. E. di Prampero, and J. Lonsdorfer
VO2 kinetics reveal a central limitation at the onset of subthreshold exercise in heart transplant recipients
J Appl Physiol, April 1, 2000; 88(4): 1228 - 1238.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
O.-E. Brodde and M. C. Michel
Adrenergic and Muscarinic Receptors in the Human Heart
Pharmacol. Rev., December 1, 1999; 51(4): 651 - 690.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
S W Dubrey and N Banner
Home inotrope treatment for intractable heart failure following heart transplantation
Heart, August 1, 1999; 82(2): 248 - 251.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. R. Henegar, D. D. Schwartz, and J. S. Janicki
ANG II-related myocardial damage: role of cardiac sympathetic catecholamines and beta -receptor regulation
Am J Physiol Heart Circ Physiol, August 1, 1998; 275(2): H534 - H541.
[Abstract] [Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
M. L. Dickstein
Anesthesia for Heart Transplantation
Seminars in Cardiothoracic and Vascular Anesthesia, July 1, 1998; 2(2): 131 - 139.
[Abstract] [PDF]


Home page
CirculationHome page
K. F. Kofoed, J. Czernin, J. Johnson, J. Kobashigawa, M. E. Phelps, H. Laks, and H. R. Schelbert
Effects of Cardiac Allograft Vasculopathy on Myocardial Blood Flow, Vasodilatory Capacity, and Coronary Vasomotion
Circulation, February 4, 1997; 95(3): 600 - 606.
[Abstract] [Full Text]


Home page
CirculationHome page
E. Aptecar, P. Dupouy, C. Benvenuti, J.-P. Mazzucotelli, E. Teiger, H. Geschwind, A. Castaigne, D. Loisance, and J.-L. Dubois-Rande
Sympathetic Stimulation Overrides Flow-Mediated Endothelium-Dependent Epicardial Coronary Vasodilation in Transplant Patients
Circulation, November 15, 1996; 94(10): 2542 - 2550.
[Abstract] [Full Text]


Home page
CirculationHome page
F. H.H. Leenen, R. A. Davies, and A. Fourney
Role of Cardiac ß2-Receptors in Cardiac Responses to Exercise in Cardiac Transplant Patients
Circulation, February 1, 1995; 91(3): 685 - 690.
[Abstract] [Full Text]


Home page
Arch Gen PsychiatryHome page
P. A. Shapiro, R. P. Sloan, E. M. Horn, M. M. Myers, and J. M. Gorman
Effect of Innervation on Heart Rate Response to Mental Stress
Arch Gen Psychiatry, April 1, 1993; 50(4): 275 - 279.
[Abstract] [PDF]